19-1220579-A-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.598-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000455.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.598-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 9 | ENST00000326873.12 | NP_000446.1 | ||
STK11 | NM_001407255.1 | c.598-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 8 | NP_001394184.1 | |||
STK11 | NR_176325.1 | n.1865-2A>G | splice_acceptor_variant, intron_variant | Intron 5 of 10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.598-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 9 | 1 | NM_000455.5 | ENSP00000324856.6 | |||
STK11 | ENST00000652231.1 | c.598-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 8 | ENSP00000498804.1 | |||||
STK11 | ENST00000585748.3 | c.226-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 11 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1429288Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 707686
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:2
This sequence change affects an acceptor splice site in intron 4 of the STK11 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). This variant is not present in population databases (ExAC no frequency). Disruptions of this splice site have been observed in several individuals affected with Peutz-Jeghers syndrome (PMID: 11389158, Invitae). This splice site is also known as IVS4-2 in the literature. ClinVar contains an entry for this variant (Variation ID: 428770). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.598-2A>G intronic pathogenic mutation results from an A to G substitution two nucleotides upstream from coding exon 5 in the STK11 gene. While c.598-2A>G has not been reported in the literature to date, another alteration at the same location, c.598-2A>T (also referred to as IVS4-2A>T), has been detected in Peutz-Jeghers cohorts (Olschwang S et al. J. Med. Genet. 2001 Jun; 38(6):356-60; Hearle N et al. Clin. Cancer Res. 2006 May; 12(10):3209-15). In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at